(Q33611931)

28 July 2017

1 reference

title

Treatment of epilepsy in pregnancy (English)

1 reference

28 July 2017

Nulman I

1

1 reference

28 July 2017

Laslo D

series ordinal

2

1 reference

28 July 2017

Koren G

series ordinal

3

1 reference

28 July 2017

publication date

1 April 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

57

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

535-544

1 reference

PIVKA-II (protein induced by vitamin K absence-II) status in newborns exposed to anticonvulsant drugs in utero

28 July 2017

cites work

1 reference

12 December 2020

1 reference

12 December 2020

Glomerular filtration during and after pregnancy.

1 reference

12 December 2020

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

1 reference

12 December 2020

Plasma volume in normal first pregnancy

1 reference

12 December 2020

A review of vitamin K, epilepsy and pregnancy

1 reference

12 December 2020

Pharmacologic treatment of nausea and vomiting during pregnancy

1 reference

12 December 2020

Management of epilepsy during pregnancy and lactation

1 reference

12 December 2020

Reduced fertility and neuroendocrine dysfunction in women with epilepsy

1 reference

12 December 2020

Marriage and fertility in epileptic patients

1 reference

12 December 2020

Detection of vitamin K deficiency by use of an enzyme-linked immunosorbent assay for circulating abnormal prothrombin

1 reference

12 December 2020

Carbamazepine protein binding and disposition in pregnancy

1 reference

12 December 2020

Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency

1 reference

12 December 2020

Fetal alcohol syndrome and DiGeorge anomaly: critical ethanol exposure periods for craniofacial malformations as illustrated in an animal model

1 reference

12 December 2020

Inhibitory effect of diphenylhydantoin on myometrium from pregnant women in vitro. A comparative study with nicardipine and trifluoperazine

1 reference

12 December 2020

Pregnancy complications and outcomes in a cohort of women with epilepsy

1 reference

12 December 2020

The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents

1 reference

12 December 2020

Minor anomalies in children of mothers with epilepsy

1 reference

12 December 2020

Pregnancy-induced changes in drug metabolism in epileptic women

1 reference

12 December 2020

Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome

1 reference

12 December 2020

Serum folic acid levels in epileptic mothers and their relationship to congenital malformations

1 reference

12 December 2020

Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan

1 reference

12 December 2020

Minor anomalies in offspring of epileptic mothers

1 reference

12 December 2020

Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations

1 reference

12 December 2020

Pharmacokinetic changes during pregnancy and their clinical relevance

1 reference

12 December 2020

Drugs in pregnancy: anticonvulsants

1 reference

12 December 2020

Spina bifida in infants of women treated with carbamazepine during pregnancy

1 reference

12 December 2020

Menstrual disorders in women with epilepsy receiving carbamazepine

1 reference

12 December 2020

Current issues in the treatment of epilepsy

1 reference

12 December 2020

Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: Human studies

1 reference

12 December 2020

Vitamin K deficiency bleeding in infants and children

1 reference

12 December 2020

Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy

1 reference

12 December 2020

Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome

1 reference

12 December 2020

Pregnancy and birth in women with epilepsy

1 reference

12 December 2020

Clinical and pharmacokinetic observations on sodium valproate - a 5-year follow-up study in 100 children with epilepsy.

1 reference

12 December 2020

Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy

1 reference

12 December 2020

Graphic Estimation of Phenytoin Dose in Adults and Children

1 reference

12 December 2020

Pharmacokinetic optimisation of anticonvulsant therapy

1 reference

12 December 2020

Birth control failure among patients with unwanted pregnancies: 1982-1984

1 reference

12 December 2020

The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort

1 reference

12 December 2020

Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy

1 reference

12 December 2020

[New aspects of hemorrhagic disease of the newborn.]

1 reference

12 December 2020

Pregnancy and epilepsy.

1 reference

12 December 2020

Antiepileptic drug therapy and reproductive consequences: functional and morphologic effects

1 reference

12 December 2020

Teratogenicity of antiepileptic drugs: analysis of possible risk factors

1 reference

12 December 2020

Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy

1 reference

12 December 2020

Antiepileptic drug disposition during pregnancy

1 reference

12 December 2020

ACOG educational bulletin. Seizure disorders in pregnancy. Number 231, December 1996. Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists

1 reference

12 December 2020

Individual and combined antiepileptic and neurotoxic activity of carbamazepine and carbamazepine-10,11-epoxide in mice.

1 reference

12 December 2020

Prenatal prediction of risk of the fetal hydantoin syndrome

1 reference

12 December 2020

Plasma concentrations of vitamin K1 and PIVKA-II in bottle-fed and breast-fed infants with and without vitamin K prophylaxis at birth

1 reference

12 December 2020

1 reference

12 December 2020

Clinical and experimental studies linking oxidative metabolism to phenytoin-induced teratogenesis

1 reference

12 December 2020

Pattern of malformations in the children of women treated with carbamazepine during pregnancy

1 reference

12 December 2020

Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications

1 reference

12 December 2020

Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy.

1 reference

12 December 2020

Use of oral contraceptives by women with epilepsy

1 reference

12 December 2020

Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine)

1 reference

12 December 2020

Mechanisms of teratogenesis: folic acid and antiepileptic therapy

1 reference

12 December 2020

Carbamazepine-10,11-epoxide in epilepsy. A pilot study

1 reference

12 December 2020

Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

1 reference

12 December 2020

10.2165/00003495-199957040-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1017436516

0 references

1 reference